Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
The initiation and management of anticoagulation is a fundamental practice for a wide variety of indications in cardiovascular critical care, including the management of patients with acute MI, stroke prevention in patients with AF or mechanical valves, as well as the prevention of device thrombosis...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-02-01
|
| Series: | Cardiac Failure Review |
| Online Access: | https://www.cfrjournal.com/articles/viscoelastic-haemostatic-assays-cardiovascular-critical-care |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850104248379899904 |
|---|---|
| author | Aniket S Rali Ahmed M Salem Melat Gebre Taylor M Garies Siva Taduru Arthur W Bracey |
| author_facet | Aniket S Rali Ahmed M Salem Melat Gebre Taylor M Garies Siva Taduru Arthur W Bracey |
| author_sort | Aniket S Rali |
| collection | DOAJ |
| description | The initiation and management of anticoagulation is a fundamental practice for a wide variety of indications in cardiovascular critical care, including the management of patients with acute MI, stroke prevention in patients with AF or mechanical valves, as well as the prevention of device thrombosis and thromboembolic events with the use of mechanical circulatory support and ventricular assist devices. The frequent use of antiplatelet and anticoagulation therapy, in addition to the presence of concomitant conditions that may lead to a propensity to bleed, such as renal and liver dysfunction, present unique challenges. The use of viscoelastic haemostatic assays provides an additional tool allowing clinicians to strike a delicate balance of attaining adequate anticoagulation while minimising the risk of bleeding complications. In this review, the authors discuss the role that viscoelastic haemostatic assay plays in cardiac populations (including cardiac surgery, heart transplantation, extracorporeal membrane oxygenation, acute coronary syndrome and left ventricular assist devices), and identify areas in need of further study. |
| format | Article |
| id | doaj-art-c564d77b82794e2784fb8683204eb9c6 |
| institution | DOAJ |
| issn | 2057-7540 2057-7559 |
| language | English |
| publishDate | 2021-02-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | Cardiac Failure Review |
| spelling | doaj-art-c564d77b82794e2784fb8683204eb9c62025-08-20T02:39:22ZengRadcliffe Medical MediaCardiac Failure Review2057-75402057-75592021-02-01710.15420/cfr.2020.22Viscoelastic Haemostatic Assays in Cardiovascular Critical CareAniket S Rali0Ahmed M Salem1Melat Gebre2Taylor M Garies3Siva Taduru4Arthur W Bracey5Division of Cardiovascular Medicine, Vanderbilt University Medical Centre, Nashville, Tennessee, USDivision of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, Texas, USDepartment of Anaesthesiology, Emory University School of Medicine, Atlanta, Georgia, USDepartment of Nursing, Vanderbilt University Medical Centre, Nashville, Tennessee, USDepartment of Cardiovascular Diseases, University of Kansas Medical Centre, Kansas City, Kansas, USDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USThe initiation and management of anticoagulation is a fundamental practice for a wide variety of indications in cardiovascular critical care, including the management of patients with acute MI, stroke prevention in patients with AF or mechanical valves, as well as the prevention of device thrombosis and thromboembolic events with the use of mechanical circulatory support and ventricular assist devices. The frequent use of antiplatelet and anticoagulation therapy, in addition to the presence of concomitant conditions that may lead to a propensity to bleed, such as renal and liver dysfunction, present unique challenges. The use of viscoelastic haemostatic assays provides an additional tool allowing clinicians to strike a delicate balance of attaining adequate anticoagulation while minimising the risk of bleeding complications. In this review, the authors discuss the role that viscoelastic haemostatic assay plays in cardiac populations (including cardiac surgery, heart transplantation, extracorporeal membrane oxygenation, acute coronary syndrome and left ventricular assist devices), and identify areas in need of further study.https://www.cfrjournal.com/articles/viscoelastic-haemostatic-assays-cardiovascular-critical-care |
| spellingShingle | Aniket S Rali Ahmed M Salem Melat Gebre Taylor M Garies Siva Taduru Arthur W Bracey Viscoelastic Haemostatic Assays in Cardiovascular Critical Care Cardiac Failure Review |
| title | Viscoelastic Haemostatic Assays in Cardiovascular Critical Care |
| title_full | Viscoelastic Haemostatic Assays in Cardiovascular Critical Care |
| title_fullStr | Viscoelastic Haemostatic Assays in Cardiovascular Critical Care |
| title_full_unstemmed | Viscoelastic Haemostatic Assays in Cardiovascular Critical Care |
| title_short | Viscoelastic Haemostatic Assays in Cardiovascular Critical Care |
| title_sort | viscoelastic haemostatic assays in cardiovascular critical care |
| url | https://www.cfrjournal.com/articles/viscoelastic-haemostatic-assays-cardiovascular-critical-care |
| work_keys_str_mv | AT aniketsrali viscoelastichaemostaticassaysincardiovascularcriticalcare AT ahmedmsalem viscoelastichaemostaticassaysincardiovascularcriticalcare AT melatgebre viscoelastichaemostaticassaysincardiovascularcriticalcare AT taylormgaries viscoelastichaemostaticassaysincardiovascularcriticalcare AT sivataduru viscoelastichaemostaticassaysincardiovascularcriticalcare AT arthurwbracey viscoelastichaemostaticassaysincardiovascularcriticalcare |